Pfizer

Pharmaceutical Company

Based in NY

🤖

AI Overview

With $1.0M in lobbying spend across 19 quarterly filings, Pfizer is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2021 to 2025.

$1.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2021	$80K
2022	$240K
2023	$240K
2024	$240K
2025	$240K

Issues Lobbied

Health Issues

Lobbying Firms

Federal Health Policy Strategies

Lobbyists

Dan Elling Cookab Hashemi Colin Roskey

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

•Issues related to drug pricing

•Drug pricing reform
•H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act
•Biosimilar utilization policy
•S.912/H.R. 1978--the Protecting Seniors Through Immunization Act of 2021

•Drug pricing reform
•H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act
•Biosimilar utilization policy
•S.912/H.R. 1978--the Protecting Seniors Through Immunization Act of 2021
•H.R. 197--Federal Account

•Drug pricing and coverage reforms H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act--biosimilar utilization policy S. 912/H.R. 197 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Pr

•Drug pricing reform, H.R.3-Elijah E. Cummings Lower Drug Costs Now Act Biosimilar utilization policy S. 912/H.R. 197 S.91 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Protecting Se